Home LiteratureArticle Details
PMID: 648026 Published · ppublish English Journal Article

Correlation between immune complexes and prognostic factors in Hodgkin's disease.

Clinical and experimental immunology ·Vol. 31 ·No. 2 ·1978-02-00 ·Pages 166-73

Amlot PL, Pussell B, Slaney JM, Williams BD

Abstract

暂无摘要

MeSH Terms
Antigen-Antibody Complex Complement C1/metabolism Complement C3/analysis Hodgkin Disease/immunology,pathology Humans Prognosis
Chemicals
Antigen-Antibody Complex Complement C1 Complement C3
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Amlot P L
Pussell B
Slaney J M
Williams B D
References (17)
17 references, click to expand
  1. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
    Clin Exp Immunol. 1976 Dec;26(3):520-7 PMID: 1009684
  2. Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.
    Clin Exp Immunol. 1977 Aug;29(2):342-54 PMID: 332422
  3. Use of bovine conglutinin for the assay of immune complexes.
    J Immunol. 1977 Apr;118(4):1428-34 PMID: 850071
  4. Immune complexes and complement hypercatabolism in patients with leprosy.
    Clin Exp Immunol. 1976 Dec;26(3):388-96 PMID: 1009681
  5. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
    Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5 PMID: 5288389
  6. Subclinical immune complex nephritis in patients with Hodgkin's disease.
    Cancer Res. 1974 May;34(5):1179-81 PMID: 4276372
  7. The pathology and nomenclature of Hodgkin's disease.
    Cancer Res. 1966 Jun;26(6):1063-83 PMID: 5947336
  8. [Nonspecific mesenchymal reactions and parenchymal damages in the liver of patients with Hodgkin's disease].
    Klin Wochenschr. 1970 Jan 15;48(2):126-8 PMID: 5521215
  9. Report of the Committee on Hodgkin's Disease Staging Classification.
    Cancer Res. 1971 Nov;31(11):1860-1 PMID: 5121694
  10. Reticuloendothelial system phagocytic function in patients with Hodgkin's disease.
    J Clin Invest. 1967 May;46(5):855-62 PMID: 5337858
  11. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Nat New Biol. 1972 Aug 9;238(84):185-6 PMID: 4340574
  12. Circulating immune complexes and symptoms in Hodgkin's disease.
    Lancet. 1976 Feb 28;1(7957):449-51 PMID: 55719
  13. Serum I-K (immunoconglutinins) in Hodgkin's disease.
    Biomedicine. 1975 Feb 28;23(2):52-4 PMID: 1167255
  14. Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.
    J Immunol. 1976 Mar;116(3):724-30 PMID: 1254951
  15. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    J Immunol. 1976 Jan;116(1):232-5 PMID: 1245740
  16. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    J Clin Invest. 1975 Jul;56(1):165-76 PMID: 1141431
  17. A simple and sensitive micro-haemagglutination inhibition assay for the semi-quantitation of the third component of complement.
    J Immunol Methods. 1975 Jun;7(2-3):219-24 PMID: 1170235
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1978-02-00
Pages
166-73
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1541233
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]